PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
72.63%
Positive EBIT growth while ACB.TO is negative. John Neff might see a substantial edge in operational management.
72.63%
Positive operating income growth while ACB.TO is negative. John Neff might view this as a competitive edge in operations.
73.70%
Positive net income growth while ACB.TO is negative. John Neff might see a big relative performance advantage.
80.46%
Positive EPS growth while ACB.TO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
80.46%
Positive diluted EPS growth while ACB.TO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
33.82%
Share change of 33.82% while ACB.TO is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
33.82%
Diluted share change of 33.82% while ACB.TO is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
94.18%
Positive OCF growth while ACB.TO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
94.18%
Positive FCF growth while ACB.TO is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-35.39%
Firm’s AR is declining while ACB.TO shows 56.76%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-4.88%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-31.47%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-72.63%
We cut SG&A while ACB.TO invests at 4.64%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.